To decipher whether EEF1A1 mRNA expression can predict breast cancer patient prognosis, we first examined the recurrence-free survival (RFS), distant metastasis-free survival (DMFS) and overall survival (OS) from pooled datasets in the Kaplan-Meier plotter online tool using the median expression level as the cut-off between high and low EEF1A1 expressing tumors29. This evidence concerns the gene EEF1A1 and breast carcinoma.